GENEVA, Oct. 1 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. filed a patent application (US2026/018484) for “ANTI-MARCO AND IMMUNE CHECKPOINT INHIBITOR ADOPTIVE CELL THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCER”. With publication no. WO/2026/193014, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....